ATC Group: N01BB01 Bupivacaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01BB01 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01B Anesthetics, local
4 N01BB Amides
5 N01BB01 Bupivacaine

Active ingredients in N01BB01

Active Ingredient

Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.

Related product monographs

Document Type Information Source  
 BUPICAN Solution for injection MPI, Generic Health Products Regulatory Authority (ZA)
 EXPAREL Suspension for solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 MARCAIN HEAVY Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MARCAIN POLYAMP STERIPACK Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MARCAINE Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 SENSORCAINE Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.